Company news
PharmaCielo Ltd. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
PharmaCielo partners with Soteria Holdings Limited to license, import and wholesale its medical cannabis flower and extracts in the Polish market
May 6, 2022
PharmaCielo Announces Financial Results for the Fourth Quarter and Fiscal Year Ended December 31, 2021
April 29, 2022
Colombian Government Provides Final Commercial Guidelines Related to the Export of Dried Flower
April 4, 2022
Colombian Government Passes Regulation to Enable Dried Flower Export and Expand Industrial Applications for CBD-Based Products
February 22, 2022
PharmaCielo Signs Sales Agreement with Greenstein to Supply THC Final Products that will be Commercialized through NOWEDA, a Pharmaceutical Wholesaler to all Pharmacies Across Germany
February 14, 2022
PharmaCielo Provides Update on Latin American Sales Progress and Non-Brokered Private Placement of Debenture Units
February 4, 2022
PharmaCielo Completes Initial Tranche of Non-Brokered Private Placement of Debenture Units
December 31, 2021
PharmaCielo Announces $15.0 Million Non-Brokered Private Placement of Debenture Units
December 22, 2021
PharmaCielo Announces Q3-2021 Financial Results
November 29, 2021
PharmaCielo Announces the Appointment of Cannabis Industry Veterans Bob DeGabrielle and Will Nicholas to the Company's Board
September 1, 2021
PharmaCielo Announces Q2-2021 Financial Results and Appointment of Bill Petron as CEO
August 20, 2021
PharmaCielo Signs Sales Agreement and Makes Initial Commercial Sale to Pharmaceutical Player in Brazil
August 4, 2021
PharmaCielo Welcomes Colombian Government's New Cannabis Decree
July 26, 2021
PharmaCielo to Participate in the Cantor Fitzgerald International Cannabis Forum
June 23, 2021
PharmaCielo Makes Initial Shipment to Canadian Life Sciences Company
June 15, 2021
PharmaCielo Announces Election of Directors - Welcomes Bill Petron, a Global Operations and Cannabis Veteran, as Chairman of the Board
June 10, 2021
PharmaCielo Appoints Experienced Cannabis Executive Ian D. Atacan as Chief Financial Officer
May 31, 2021
PharmaCielo Announces Financial Results for the First Quarter Ended March 31, 2021
May 31, 2021
PharmaCielo Announces Bill Petron, a Global Operations and Cannabis Veteran, to Stand for Election as a Nominee for Chairman of the Board
May 13, 2021
PharmaCielo Provides Update on Global GMP Compliance Process
May 5, 2021
PharmaCielo Announces Financial Results for the Fourth Quarter and Fiscal Year Ended December 31, 2020
May 3, 2021
PharmaCielo Makes Initial Shipments to two Brazilian Customers
April 26, 2021
PharmaCielo Announces Closing of Overnight Marketed Equity Offering for Gross Proceeds of $13.5 Million
April 7, 2021
Mexico Votes to Advance Recreational Cannabis Legalization - PharmaCielo Mexico Positioned to Become a Preferred Supplier
March 12, 2021
PharmaCielo Ltd. Announces Upsize and Pricing of Overnight Marketed Equity Offering
March 4, 2021
PharmaCielo Ltd. Announces Overnight Marketed Equity Financing
March 3, 2021
PharmaCielo Delivers First Commercial Shipment of THC-Free Broad-Spectrum Distillate
February 18, 2021
PharmaCielo Provides Update on GMP Compliance Process
February 2, 2021
PharmaCielo Announces Appointment of Caroline Lenardon for Expansion of Retail Investor Relations Capacity
December 18, 2020
PharmaCielo Enters Strategic Alliance to Provide Pre-Tested and Insured Product to Customers in the U.S. Market
December 11, 2020
PharmaCielo Receives Approximately CDN$3.0 Million in Non-Dilutive Funding from Colombian State-Owned Banco Agrario
December 7, 2020
PharmaCielo Welcomes Landmark United Nations Decision to Remove Cannabis from Narcotic Drugs List
December 3, 2020
PharmaCielo Announces Grant of Stock Options
December 2, 2020
PharmaCielo Ltd. Announces New Leadership
November 30, 2020
PharmaCielo Announces Financial Results for the Third Quarter Ended September 30, 2020
November 30, 2020
PharmaCielo Achieves Good Agricultural and Collection Practices (GACP) Designation
November 25, 2020
PharmaCielo Announces Closing of $10M Private Placement
November 23, 2020
PharmaCielo Mexico Salutes Mexican Senate for Advancing Cannabis Legalization
November 19, 2020
PharmaCielo Enters U.K. Market with 500kg Initial Shipment to Established Manufacturer and Distributor - Reaches 2021 Agreement
November 18, 2020
PharmaCielo to Hold Conference Call to Review Third Quarter 2020 Financial Results
November 16, 2020
PharmaCielo to Participate in 2020 Cowen Boston Cannabis Conference
November 13, 2020
PharmaCielo Begins Harvest of High-THC Cultivars for Extract Export
November 5, 2020
PharmaCielo Announces Upsizing of Private Placement Offering
November 3, 2020
PharmaCielo Ltd. Expands Board Depth and Expertise with Appointment of Marc Lustig as Lead Director and Strengthens Capital Position with Private Placement Offering
November 2, 2020
PharmaCielo to Participate in Cantor Fitzgerald Latin America Cannabis Seminar
October 23, 2020
PharmaCielo Announces Financial Results for the Second Quarter Ended June 30, 2020 and Provides Operational Update
August 31, 2020
PharmaCielo to Hold Conference Call to Review Second Quarter 2020 Financial Results
August 18, 2020
PharmaCielo Increases Cannabis Cultivation Through External Contractor to Meet Market Demand for Medicinal Extracts
August 13, 2020
PharmaCielo Announces Results of AGM
August 7, 2020
PharmaCielo Receives Colombian Government Authorization for 10 Tonnes of High-THC Cultivation and Extract Production for Export
July 8, 2020
Decks
- Investor Presentation (February 2024)
Investor deck · 14 slides · February 2024
- Investor Presentation (February 2019)
Investor deck · 23 slides · February 2019
- Investor Presentation (January 2019)
Investor deck · 21 slides · January 2019
- Investor Presentation (November 2018)
Investor deck · 23 slides · November 2018